Serving 500+ biopharmaceutical companies globally:
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
Serving 500+ biopharmaceutical companies globally:
Generated: July 24, 2017
What are the generic sources for heparin sodium and what is the scope of heparin sodium freedom to operate?
Heparin sodium is the generic ingredient in thirty-eight branded drugs marketed by Hospira, Sandoz, B Braun, Solopak, Smith And Nephew, Eurohlth Intl Sarl, Watson Labs Inc, Sagent Pharms, Baxter Hlthcare, Lilly, Gland Pharma Ltd, 3M, Fresenius Kabi Usa, Pharma Serve Ny, Chamberlin Parenterl, Mcgaw, Shenzhen Techdow, Abraxis Pharm, West-ward Pharms Int, Dell Labs, Parke Davis, Luitpold, Organon Usa Inc, Intl Medication, Watson Labs, Pfizer, Pharmacia And Upjohn, Hospira Inc, Pharm Spec, and Akorn, and is included in seventy-five NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.| Tradenames: | 38 |
| Patents: | 1 |
| Applicants: | 30 |
| NDAs: | 75 |
| Drug Master File Entries: see list | 77 |
| Suppliers / Packagers: see list | 14 |
| Clinical Trials: see list | 3,002 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | see low prices |
| DailyMed Link: | heparin sodium at DailyMed |
| Ingredient-type | Heparin |
| Drug Class | Anti-coagulant Unfractionated Heparin |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Smith And Nephew | HEPARIN SODIUM | heparin sodium | INJECTABLE;INJECTION | 088239-001 | Jul 26, 1984 | DISCN | No | No | ► Subscribe | ► Subscribe | ► Subscribe | ||||||||||||||||||
Watson Labs | HEPARIN SODIUM | heparin sodium | INJECTABLE;INJECTION | 017064-019 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ► Subscribe | ► Subscribe | ► Subscribe | ||||||||||||||||||
Akorn | HEPARIN SODIUM | heparin sodium | INJECTABLE;INJECTION | 017486-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ► Subscribe | ► Subscribe | ► Subscribe | ||||||||||||||||||
3m | LIPO-HEPIN | heparin sodium | INJECTABLE;INJECTION | 017027-006 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ► Subscribe | ► Subscribe | ► Subscribe | ||||||||||||||||||
Organon Usa Inc | LIQUAEMIN SODIUM | heparin sodium | INJECTABLE;INJECTION | 000552-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ► Subscribe | ► Subscribe | ► Subscribe | ||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
Serving 500+ biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Follow DrugPatentWatch:
Join the 22,120 others who get our Drug Patent Expiration Alerts:
